Synthetic biology increasingly is moving from the laboratory to the marketplace, where it could help companies meet rising demand for sustainable materials, foods and fuels, therapies and vaccines.

Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. AI company OpenAI ...